Patents by Inventor Rainer Goldau

Rainer Goldau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000642
    Abstract: An apparatus for generating dialysate for dialysis comprising a dialysate outlet and a dialysate inlet and dialysate purifying means, wherein the purifying means comprise a cryopurifier for generating pure water, wherein the inlet of the cryopurifier is connected to the dialysate outlet and the outlet of the cryopurifier is connected to the dialysate inlet; and a method for reclaiming of fresh dialysate from ultrafiltrate and wasted dialysate extracted from a dialysis patient, comprising the following steps: preparing an ice slurry from the dialysate, wherein the ice slurry contains ice crystals and a liquid containing solutes; and separating the ice crystals from the liquid containing the solutes.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: May 11, 2021
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventor: Rainer Goldau
  • Publication number: 20190224401
    Abstract: An apparatus for generating dialysate for dialysis comprising a dialysate outlet and a dialysate inlet and dialysate purifying means, wherein the purifying means comprise a cryopurifier for generating pure water, wherein the inlet of the cryopurifier is connected to the dialysate outlet and the outlet of the cryopurifier is connected to the dialysate inlet; and a method for reclaiming of fresh dialysate from ultrafiltrate and wasted dialysate extracted from a dialysis patient, comprising the following steps: preparing an ice slurry from the dialysate, wherein the ice slurry contains ice crystals and a liquid containing solutes; and separating the ice crystals from the liquid containing the solutes.
    Type: Application
    Filed: July 24, 2017
    Publication date: July 25, 2019
    Applicant: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventor: Rainer Goldau
  • Patent number: 8953008
    Abstract: A method for producing images (8) on a substrate (2) with colour bodies thereon, the colour bodies losing a colour effect due to a laser (23) and consisting of dyes or pigments contained in capsules (1). Different colour bodies having at least three different colour effects are on or in the substrate (2). The method includes: (a) producing a colour chart (14), with individual colour effect of individual colour bodies contained as a function of the spatial coordinates thereof on or in the substrate; and (b) spatially resolving radiation, which opens the colour effect of colour bodies of individual capsules and releases dyes by a laser (23) at a single frequency on the basis of the colour chart (14) in order to produce a resultant colour effect. Substrates, like security documents, can be produced this method.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: February 10, 2015
    Assignee: U-NICA Technology AG
    Inventors: Rainer Goldau, Klaus Schafer, Ulrich Ritter
  • Patent number: 8896647
    Abstract: A method is described for producing a character, pattern, symbol and/or image (8) on a substrate (2) by way of pigment particles (1) which are arranged thereon and lose their color effect under the action of a laser (23), wherein different pigment particles (1) with at least three different color effects are arranged on and/or in the substrate (2). The invention is distinguished by the following method steps: (a) production of a color chart (14), in which the individual color effect of individual pigment particles (1) or individual clusters of pigment particles is contained as a function of their spatial coordinate on and/or in the substrate (2); (b) spatially resolved irradiation, which changes the color effect of only individual pigment particles (1) or individual clusters of pigment particles, by way of a laser (23) at a single frequency on the basis of the color chart (14) in order to produce a resulting color effect.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: November 25, 2014
    Assignee: U-NICA Technology AG
    Inventors: Rainer Goldau, Klaus Schafer
  • Publication number: 20140160220
    Abstract: What is described is a method for producing a sign, pattern, symbol and/or image (8) on a substrate (2) with colour bodies arranged on said substrate, said colour bodies losing the colour effect under the influence of a laser (23) and consisting of dyes or pigments contained in capsules (1), wherein different colour bodies (1) having at least three different colour effects are arranged on or in the substrate (2). The invention is characterised by the following method steps: (a) producing a colour chart (14), in which the individual colour effect of individual colour bodies (1) formed from dyes or pigment particles is contained as a function of the spatial coordinates thereof on or in the substrate (2); (b) spatially resolved radiation, which open the colour effect of colour bodies (1) just of individual capsules and release these dyes, by means of an excitation beam of a laser (23) at a single frequency on the basis of the colour chart (14) in order to produce a resultant colour effect.
    Type: Application
    Filed: September 12, 2012
    Publication date: June 12, 2014
    Applicant: U-NICA TECHNOLOGY AG
    Inventors: Rainer Goldau, Klaus Schafer, Ulrich Ritter
  • Publication number: 20130314486
    Abstract: A method is described for producing a character, pattern, symbol and/or image (8) on a substrate (2) by way of pigment particles (1) which are arranged thereon and lose their colour effect under the action of a laser (23), wherein different pigment particles (1) with at least three different colour effects are arranged on and/or in the substrate (2). The invention is distinguished by the following method steps: (a) production of a colour chart (14), in which the individual colour effect of individual pigment particles (1) or individual clusters of pigment particles is contained as a function of their spatial coordinate on and/or in the substrate (2); (b) spatially resolved irradiation, which changes the colour effect of only individual pigment particles (1) or individual clusters of pigment particles, by way of a laser (23) at a single frequency on the basis of the colour chart (14) in order to produce a resulting colour effect.
    Type: Application
    Filed: September 20, 2011
    Publication date: November 28, 2013
    Applicant: U-NICA TECHNOLOGY AG
    Inventors: Rainer Goldau, Klaus Schafer
  • Patent number: 7711418
    Abstract: An electroimpedance tomograph including a plurality of electrodes placed on a body, measuring circuits processing voltage signals recorded by the electrodes, and a control unit supplying two electrodes each with an alternating current. The control unit has a preset feed frequency. The control unit processes the processed voltage signals of all other electrodes to reconstruct the impedance distribution of the body in the electrode plane. The control unit provides for an automatic setting of the current feed frequency/frequencies to record a background frequency spectrum by detecting the electrode voltage signals over a preset period of time and record them as a voltage time series and transform them into a frequency spectrum. The control unit searches in the background frequency spectrum for a frequency (different states) or frequencies (different frequencies) that leads to a useful signal to background ratio above a preset threshold value when used as a feed frequency.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: May 4, 2010
    Assignee: Dräger Medical AG & Co. KG
    Inventors: Yvo Gärber, Markus Steeger, Jianhua Li, Steffen Leonhardt, Jan Rüterbories, Rainer Goldau
  • Patent number: 7077819
    Abstract: The invention relates to a method for determining the volume of distribution of a blood component in the body of a living organism, especially the volume of distribution of urea, during an extracorporeal blood treatment. According to this method, the blood to be treated flows through the blood chamber (3) of a dialysis machine (1) in an extracorporeal circuit, said dialysis machine being divided into said blood chamber and a dialysing liquid chamber (4) by a semipermeable membrane (2). Dialysing liquid flows through the dialysing liquid chamber of the dialysis machine in a dialysing liquid channel.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: July 18, 2006
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Rainer Goldau, Thomas Graf, Malte Gross
  • Publication number: 20050059901
    Abstract: An electroimpedance tomograph is provided with a plurality of electrodes placed on a body, measuring circuits that process the voltage signals recorded by the electrodes, and a control unit that supplies two, preferably adjacent electrodes each with an alternating current. The control unit has a preset feed frequency performed in different states and different preset feed frequencies performed at different frequencies. The control unit processes the processed voltage signals of all other electrodes to reconstruct the impedance distribution of the body in the electrode plane. To make the EIT more insensitive to electromagnetic interferences, the control unit provides for an automatic setting of the current feed frequency/frequencies to record a background frequency spectrum by detecting the electrode voltage signals over a preset period of time and record them as a voltage time series and transform them into a frequency spectrum.
    Type: Application
    Filed: June 30, 2004
    Publication date: March 17, 2005
    Inventors: Yvo Garber, Markus Steeger, Jianhua Li, Steffen Leonhardt, Jan Ruterbories, Rainer Goldau
  • Patent number: 6860866
    Abstract: A method and a device for determining the efficiency of a dialyzer of a dialysis machine during a dialysis treatment wherein the dialyzer is divided by a semipermeable membrane into a blood chamber and a dialysis fluid chamber and wherein the blood flows at a predetermined flow rate through the blood chamber and dialysis fluid flows at a predetermined flow rate through the dialysis fluid chamber. In use, the dialysance or clearance for a predetermined dialysis fluid flow rate and/or blood flow rate is measured, and then the dialysance or clearance for any dialysis fluid flow rate and blood flow rate is calculated.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: March 1, 2005
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Thomas Graf, Christoph Bardorz, Malte Gross, Rainer Goldau
  • Patent number: 6217539
    Abstract: To be able to optimize the hemodialysis treatment process, in-vivo determination of important parameters, such as the exchange efficiency of the dialyzer, represented by the dialysance or clearance, is desirable. Mathematical quantification of the blood purification processes on the basis of measurement technology is especially important. Important measured quantities and operands for the determination of the desired parameter are usually the dialysate flow and the blood flow (Qd, Qb), the inlet and outlet concentrations (cdi, cdo) of the dialysis fluid and the electrolyte transfer rate derived from it as well as the formulation of the mass balance in the dialyzer.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: April 17, 2001
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventor: Rainer Goldau
  • Patent number: 6187199
    Abstract: A method is described for determining hemodialysis parameters during an extracorporeal blood treatment according to which the blood to be treated in an extracorporeal circulation flows through the blood chamber of a dialyzer divided by a semipermeable membrane into the blood chamber and a dialysate chamber, and dialysate in a dialysate path flows through the dialysate chamber of the dialyzer. According to the method pursuant to the invention, the hemodialysis parameter can also be determined when no balanced state has yet been established. The method according to the invention is based on the response of the dialyzer to a pulse function as inlet signal (pulse response) from the course over time of the physical or chemical characteristic quantity of the dialysate upstream and downstream of the dialyzer. The hemodynamic parameter is then determined from the pulse response of the dialyzer.
    Type: Grant
    Filed: April 26, 1999
    Date of Patent: February 13, 2001
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventor: Rainer Goldau
  • Patent number: 6126831
    Abstract: A device and method are described to determine the concentration of a substance in blood flowing through a blood chamber of a dialyzer during extra corporeal blood treatment. The flow rate of dialysate flowing through the dialysate chamber of the dialyzer is reduced to a value at which the concentration of the substance at the outlet of the dialysate chamber is essentially the same as the concentration of that same substance in the blood at the inlet of the blood chamber. The concentration measurement can be carried out without interrupting the flow of dialysate.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: October 3, 2000
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Rainer Goldau, Matthias Kramer
  • Patent number: 6077443
    Abstract: In a method and device for monitoring a vascular access during a dialysis treatment, pressure pulses generated by a balancing device connected in a dialysis fluid inlet line and drain line are monitored in the extracorporeal blood circulation path. The pressure pulses are detected with a pressure sensor in the venous blood line and are analyzed in an analyzer unit. When there is a characteristic change in pressure pulses in the extracorporeal blood circulation path, a faulty venous access is deduced, i.e., the needle has slipped out. Upon a faulty venous access condition, an alarm generator generates an acoustic and/or optical alarm, and the blood flow in the extracorporeal circulation is interrupted.
    Type: Grant
    Filed: August 5, 1998
    Date of Patent: June 20, 2000
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventor: Rainer Goldau